24.08.2013 Views

2008 Barcelona - European Society of Human Genetics

2008 Barcelona - European Society of Human Genetics

2008 Barcelona - European Society of Human Genetics

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Prenental diagnostics<br />

nuchal translucency . Cytogenetic analysis after short-term culture<br />

showed four different abnormal cell lines involving chromosome 18,<br />

and the karyotype was described as:<br />

mos 46,XX,18p+[15]/r(18)[14]/i(18q)[1]/45,XX,-18[3] . Amniocentesis<br />

was subsequently performed . Ultrasound examination showed a<br />

septate translucency as the only abnormal finding. QF-PCR analysis<br />

showed homozygosity for all 18p markers, suggesting a 18p monosomy<br />

. The karyotype obtained was 46,XX,del(18p) in all cells . The pregnancy<br />

was terminated and pathologic studies are being performed at<br />

present. We propose a model to explain the cytogenetic findings. A first<br />

postzygotic error, probably an unequal sister chromatid exchange giving<br />

rise to a cell line with del(18p) and the complementary with 18p+,<br />

may have most likely happened before the first post-zygotic division,<br />

since no normal cells have been detected . Isochromosome(18q) and<br />

ring(18) seem to be secondary to del(18p), and monosomy 18 may<br />

have derived from the ring(18) cell line, given the instability <strong>of</strong> rings . An<br />

unequal distribution <strong>of</strong> the different cell lines between the trophoblast<br />

and the inner cell mass, and differences on the viability <strong>of</strong> each cell<br />

line in different tissues, may explain why the fetal tissues only show the<br />

18p deletion whereas the trophoblast presents the other cell lines .<br />

P03.64<br />

Uptake <strong>of</strong> prenatal diagnosis after established carrier status <strong>of</strong><br />

a balanced structural chromosome abnormality in couples with<br />

recurrent miscarriage<br />

F. Vansenne, J. C. Korevaar, M. T. M. Franssen, N. J. Leschot, F. van der<br />

Veen, P. M. M. Bossuyt, C. A. J. M. de Borgie, M. Goddijn;<br />

Academic Medical Centre, Amsterdam, The Netherlands.<br />

Three to six percent <strong>of</strong> couples with recurrent miscarriage are carriers<br />

<strong>of</strong> a structural chromosome abnormality . These carriers are <strong>of</strong>fered<br />

prenatal diagnosis (PND) in subsequent pregnancies . It is unknown<br />

what the effect is <strong>of</strong> disclosure <strong>of</strong> the abnormal result <strong>of</strong> karyotyping in<br />

carrier couples on the uptake <strong>of</strong> PND in subsequent pregnancies . This<br />

study evaluates the uptake <strong>of</strong> PND in carrier couples compared with<br />

non-carrier couples .<br />

We collected data <strong>of</strong> 239 carrier and 389 non-carrier couples presenting<br />

for parental karyotyping after two or more miscarriages < 20 weeks<br />

<strong>of</strong> gestation in six centers for Clinical <strong>Genetics</strong> in the Netherlands,<br />

from 1992-2001 . PND procedures in subsequent pregnancies were<br />

recorded for a minimum <strong>of</strong> 24 months .<br />

Within the carrier couples 150 out <strong>of</strong> 239 (63%) underwent a PNDprocedure<br />

in at least one subsequent pregnancy compared to 111 out<br />

<strong>of</strong> 389 non-carrier couples (29%) (p

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!